FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211069439> ?p ?o ?g. }

• W3211069439 endingPage "1713" @default.
• W3211069439 startingPage "1713" @default.
• W3211069439 abstract "The optimal dose and duration of oral amoxicillin for children with community-acquired pneumonia (CAP) are unclear.To determine whether lower-dose amoxicillin is noninferior to higher dose and whether 3-day treatment is noninferior to 7 days.Multicenter, randomized, 2 × 2 factorial noninferiority trial enrolling 824 children, aged 6 months and older, with clinically diagnosed CAP, treated with amoxicillin on discharge from emergency departments and inpatient wards of 28 hospitals in the UK and 1 in Ireland between February 2017 and April 2019, with last trial visit on May 21, 2019.Children were randomized 1:1 to receive oral amoxicillin at a lower dose (35-50 mg/kg/d; n = 410) or higher dose (70-90 mg/kg/d; n = 404), for a shorter duration (3 days; n = 413) or a longer duration (7 days; n = 401).The primary outcome was clinically indicated antibiotic re-treatment for respiratory infection within 28 days after randomization. The noninferiority margin was 8%. Secondary outcomes included severity/duration of 9 parent-reported CAP symptoms, 3 antibiotic-related adverse events, and phenotypic resistance in colonizing Streptococcus pneumoniae isolates.Of 824 participants randomized into 1 of the 4 groups, 814 received at least 1 dose of trial medication (median [IQR] age, 2.5 years [1.6-2.7]; 421 [52%] males and 393 [48%] females), and the primary outcome was available for 789 (97%). For lower vs higher dose, the primary outcome occurred in 12.6% with lower dose vs 12.4% with higher dose (difference, 0.2% [1-sided 95% CI -∞ to 4.0%]), and in 12.5% with 3-day treatment vs 12.5% with 7-day treatment (difference, 0.1% [1-sided 95% CI -∞ to 3.9]). Both groups demonstrated noninferiority with no significant interaction between dose and duration (P = .63). Of the 14 prespecified secondary end points, the only significant differences were 3-day vs 7-day treatment for cough duration (median 12 days vs 10 days; hazard ratio [HR], 1.2 [95% CI, 1.0 to 1.4]; P = .04) and sleep disturbed by cough (median, 4 days vs 4 days; HR, 1.2 [95% CI, 1.0 to 1.4]; P = .03). Among the subgroup of children with severe CAP, the primary end point occurred in 17.3% of lower-dose recipients vs 13.5% of higher-dose recipients (difference, 3.8% [1-sided 95% CI, -∞ to10%]; P value for interaction = .18) and in 16.0% with 3-day treatment vs 14.8% with 7-day treatment (difference, 1.2% [1-sided 95% CI, -∞ to 7.4%]; P value for interaction = .73).Among children with CAP discharged from an emergency department or hospital ward (within 48 hours), lower-dose outpatient oral amoxicillin was noninferior to higher dose, and 3-day duration was noninferior to 7 days, with regard to need for antibiotic re-treatment. However, disease severity, treatment setting, prior antibiotics received, and acceptability of the noninferiority margin require consideration when interpreting the findings.ISRCTN Identifier: ISRCTN76888927." @default.
• W3211069439 created "2021-11-08" @default.
• W3211069439 creator A5000726333 @default.
• W3211069439 creator A5001012202 @default.
• W3211069439 creator A5001488175 @default.
• W3211069439 creator A5001844277 @default.
• W3211069439 creator A5002313898 @default.
• W3211069439 creator A5003247288 @default.
• W3211069439 creator A5003944041 @default.
• W3211069439 creator A5006397058 @default.
• W3211069439 creator A5007837109 @default.
• W3211069439 creator A5008119210 @default.
• W3211069439 creator A5008216930 @default.
• W3211069439 creator A5008442184 @default.
• W3211069439 creator A5008926524 @default.
• W3211069439 creator A5009263396 @default.
• W3211069439 creator A5009455397 @default.
• W3211069439 creator A5010156236 @default.
• W3211069439 creator A5010474722 @default.
• W3211069439 creator A5010728414 @default.
• W3211069439 creator A5010744070 @default.
• W3211069439 creator A5011072569 @default.
• W3211069439 creator A5011276908 @default.
• W3211069439 creator A5011810802 @default.
• W3211069439 creator A5011831624 @default.
• W3211069439 creator A5013091805 @default.
• W3211069439 creator A5013255875 @default.
• W3211069439 creator A5013423192 @default.
• W3211069439 creator A5013629942 @default.
• W3211069439 creator A5014497512 @default.
• W3211069439 creator A5015306937 @default.
• W3211069439 creator A5015666894 @default.
• W3211069439 creator A5016064160 @default.
• W3211069439 creator A5017826490 @default.
• W3211069439 creator A5019081446 @default.
• W3211069439 creator A5019562674 @default.
• W3211069439 creator A5019803514 @default.
• W3211069439 creator A5020649067 @default.
• W3211069439 creator A5020832353 @default.
• W3211069439 creator A5021323660 @default.
• W3211069439 creator A5021334636 @default.
• W3211069439 creator A5022034704 @default.
• W3211069439 creator A5023218418 @default.
• W3211069439 creator A5023735316 @default.
• W3211069439 creator A5024153176 @default.
• W3211069439 creator A5024243028 @default.
• W3211069439 creator A5024619166 @default.
• W3211069439 creator A5024783432 @default.
• W3211069439 creator A5025928587 @default.
• W3211069439 creator A5025984619 @default.
• W3211069439 creator A5026415916 @default.
• W3211069439 creator A5026480684 @default.
• W3211069439 creator A5026663108 @default.
• W3211069439 creator A5026733155 @default.
• W3211069439 creator A5026988583 @default.
• W3211069439 creator A5029134034 @default.
• W3211069439 creator A5029209913 @default.
• W3211069439 creator A5029431552 @default.
• W3211069439 creator A5029508707 @default.
• W3211069439 creator A5029534015 @default.
• W3211069439 creator A5029987223 @default.
• W3211069439 creator A5031494343 @default.
• W3211069439 creator A5031593205 @default.
• W3211069439 creator A5032510884 @default.
• W3211069439 creator A5033092905 @default.
• W3211069439 creator A5034074946 @default.
• W3211069439 creator A5034393834 @default.
• W3211069439 creator A5034474970 @default.
• W3211069439 creator A5034721183 @default.
• W3211069439 creator A5034783056 @default.
• W3211069439 creator A5035201271 @default.
• W3211069439 creator A5035322549 @default.
• W3211069439 creator A5035826989 @default.
• W3211069439 creator A5036202060 @default.
• W3211069439 creator A5037390982 @default.
• W3211069439 creator A5037575744 @default.
• W3211069439 creator A5037952492 @default.
• W3211069439 creator A5038605823 @default.
• W3211069439 creator A5039160195 @default.
• W3211069439 creator A5040544657 @default.
• W3211069439 creator A5040884085 @default.
• W3211069439 creator A5041622112 @default.
• W3211069439 creator A5042857660 @default.
• W3211069439 creator A5043723375 @default.
• W3211069439 creator A5043853819 @default.
• W3211069439 creator A5044577605 @default.
• W3211069439 creator A5044780114 @default.
• W3211069439 creator A5044840069 @default.
• W3211069439 creator A5046673368 @default.
• W3211069439 creator A5047234474 @default.
• W3211069439 creator A5050272498 @default.
• W3211069439 creator A5050877302 @default.
• W3211069439 creator A5051442895 @default.
• W3211069439 creator A5051637016 @default.
• W3211069439 creator A5052128185 @default.
• W3211069439 creator A5052245125 @default.
• W3211069439 creator A5052269084 @default.
• W3211069439 creator A5052283572 @default.

• next